Jul 24, 2026
For decades, the diagnosis and monitoring of cancer have depended heavily on tissue biopsy, a procedure that involves surgically or percutaneously removing a piece of tumor for pathological examination. While tissue biopsy remains the diagnostic gold standard, it is invasive, carries procedural risk, cannot always ...
Read More...
Jul 23, 2026
Seegene USA Received FDA Emergency Use Authorization for Multiplex PCR Assay, Advancing Differential Diagnosis of HSV-1&2, VZV, and Monkeypox Virus for Ulcerative Skin Lesions On 21 July 2026, Seegene USA received U.S. FDA Emergency Use Authorization (EUA) for its Allplex™ HSV-1&2/VZV/MPXV Assay, the fir...
Read More...
Jul 08, 2026
For decades, prescribing medicine has followed a "one-size-fits-all" playbook: a standard drug, a standard dose, and a hopeful wait to see how the patient responds. The pharmacogenomic testing service is quietly dismantling that model. By reading the genetic variants that govern how an individual absorbs, metaboliz...
Read More...
Jul 01, 2026
DNA diagnostics is no longer a niche laboratory technique reserved for research institutions, it has become one of the fastest-growing pillars of modern medicine. By analyzing genetic material to detect mutations, pathogens, and chromosomal abnormalities, DNA-based testing is transforming how diseases are predicted...
Read More...
Jun 18, 2026
FiberSense Continuous Glucose Monitoring (CGM) System obtains CE mark as commercial launch preparations begin On 17 June 2026, FiberSense AG announced that its FiberSense Continuous Glucose Monitoring (CGM) System had received CE marking under Regulation (EU) 2017/745 as a Class IIb medical device. T...
Read More...
Mar 25, 2026
Molecular diagnostics is a rapidly advancing field within laboratory medicine that applies molecular biology techniques to detect and quantify specific DNA or RNA sequences. By enabling earlier detection, greater diagnostic accuracy, and more informed clinical decision-making, these technologies have become indispe...
Read More...
May 03, 2023
Cancer is a global burden, leading to a significant number of death and disabilities worldwide. In 2020, nearly one in six deaths were related to cancer. Breast cancer, lung cancer, colon and rectum cancer, and prostate cancer are some of the major cancer types, registering the highest number of cases globally. To ...
Read More...
Apr 12, 2023
Polymerase Chain Reaction, commonly called PCR, is one of the most well-known methods in molecular biology utilized for amplifying target sequences from a DNA template in an exponential manner. PCR has various applications, and the scope is vast in healthcare and other related domains. It was invented in 1983 by Am...
Read More...
Mar 02, 2023
AI-powered Sensora Platform Launched by Eko for Cardiac Disease Detection On February 23, 2023, Eko, a digital healthcare company employing artificial intelligence (AI) against heart and lung disease, announced the launch of its SENSORA™ Cardiac Disease Detection Platform. The stethoscope, one of the m...
Read More...
Feb 27, 2023
Measurable or Minimal Residual Disease (MRD) is a term often used when treating patients with blood cancers. MRD is a small number of cancer cells left in the body after cancer treatment, and these cells can potentially cause relapse in these patients. The number of remaining cells is often too small to cause any s...
Read More...
The Next Wave of Radioligand Therapies: 5 Candidates to Watch
Mar 20, 2026
Emerging TIL Therapies Poised to Broaden the Landscape Beyond AMTAGVI
Mar 06, 2026
Newsletter/Whitepaper